18 Oct 2018 | 1:53 PM
 

Dr. Reddy`s Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 500124 | NSE Symbol: DRREDDY
2,562.35
-11.10
(-0.43 %)
17 Oct 2018 | 03:51 PM
Change company
  • Open (Rs)
    2,577.06
  • Prev. close (Rs.)
    2,573.45
  • High (Rs.)
    2,598.95
  • Low (Rs.)
    2,551.00
  • 52W H (Rs.)
    2,687.45
  • 52W L (Rs.)
    1,888.00
  • Volume
    20987
  • MCap (Rs in Cr.)
    42,528.10

Stock Market News

Dr. Reddy`s Laboratories Ltd. Stock News

Company Name
From Date
To Date
  Dr. Reddy`s Laboratories Ltd. | 15 Oct 2018 | 12:27:00
Stocks of Dr. Reddy`s Laboratories surged nearly 2 per cent on Bombay Stock Exchange after drug maker said it had signed a definitive agreement to sell its active pharmaceutical ingredient (API) manufacturing business unit located in Jeedimetla Hyderabad...
  Dr. Reddy`s Laboratories Ltd. | 15 Oct 2018 | 11:09:00
Dr Reddy`s Laboratories Ltd Monday said it entered into a definitive agreement for the sale of its API Active Pharmaceutical Ingredients (API)
manufacturingbusiness unit located in Jeedimetla here to Therapiva Private Ltd an emerging generics pharmaceu...
  Dr. Reddy`s Laboratories Ltd. | 10 Oct 2018 | 12:27:00
Drug major Dr Reddy`s Laboratories Tuesday said it has launched Colesevelam Hydrochloride tablets used for lowering of cholesterol in the US market...
  Dr. Reddy`s Laboratories Ltd. | 03 Oct 2018 | 00:33:00
Dr Reddy`s Laboratories (DRL) said its wholly-owned subsidiary Promius Pharma has sold rights of cloderm cream and its authorised generic to EPI Health LLC reported PTI...
  Dr. Reddy`s Laboratories Ltd. | 01 Oct 2018 | 09:24:00
Dr. Reddy`s Laboratories Ltd. has said that it has closed the sale of its antibiotic manufacturing facility and related assets in Bristol Tennessee to Neopharma Inc...
  Dr. Reddy`s Laboratories Ltd. | 01 Oct 2018 | 09:24:00
Dr. Reddy`s Laboratories Ltd. has said that it has launched lmatinib Mesylate Tablets USP a therapeutic equivalent generic version of Gleevec (imatinib mesylate) Tablets in the United States market approved by the U.S. Food and Drug Administration (USFDA)...
  Dr. Reddy`s Laboratories Ltd. | 01 Oct 2018 | 09:23:00
Dr. Reddy`s Laboratories Ltd. has said that it has terminated the license granted to Armis Biopharma Inc. (formerly known as CHO Bioscience Inc.) for its investigational antibacterial product DFA-02 for the prophylaxis of surgical site infections (SSls) ...